Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: No official release...look at PTSC's website

<!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} </style> <![endif]-->

<questions of fact that are the domain of the jury. For this reason, the courts often let the jury decide>

In general that is correct, just not in the case of patents.

<<In general, a summary judgment is difficult to obtain because the non-moving party can usually find a factual issue that is disputed. However, summary judgments are not uncommon in patent cases even though the issue of infringement includes factual inquiries.>>

I suspect for the same reason juries do not construe claims. They do not have the technical expertise.

Opty

Share
New Message
Please login to post a reply